Loading…
Jubilant Ingrevia Ltd will acquire a 40% stake in Zettaone Technologies India Pvt Ltd for ₹189.2 crore, to be completed in two tranches by November 2026 and September 2027.
Jubilant Ingrevia has received a CDMO contract worth Rs 270 crore from an international customer to supply two GMP intermediates for a patented drug over three years. Commercial supplies will start in the current financial year.